Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Zhonghua Gan Zang Bing Za Zhi ; 32(3): 257-261, 2024 Mar 20.
Article in Chinese | MEDLINE | ID: mdl-38584111

ABSTRACT

Systemic treatment, including molecular targeted therapy, immunotherapy, and chemotherapy, is an important means of achieving long-term survival in patients with intermediate-and advanced-stage liver cancer. However, some patients are insensitive to treatment and even develop drug resistance. Mitochondria are the center of cellular energy metabolism and, at the same time, are the priority targets for systemic therapy. Mitochondrial homeostasis plays an important role in the treatment of liver cancer. The relationship between the two advances is elucidated so as to provide better ideas for the clinical treatment of liver cancer.


Subject(s)
Liver Neoplasms , Mitochondria , Humans , Immunotherapy , Liver Neoplasms/therapy , Liver Neoplasms/metabolism , Homeostasis
2.
Zhonghua Gan Zang Bing Za Zhi ; 31(10): 1108-1112, 2023 Oct 20.
Article in Chinese | MEDLINE | ID: mdl-38016782

ABSTRACT

Molecular targeted drugs are one of the treatments for hepatocellular carcinoma (HCC), the primary factor influencing their therapeutic efficacy is drug resistance. Diminished drug intake, greater efflux, improved DNA damage repair capacity, aberrant signal pathways, hypoxia, epithelial-mesenchymal cell transition, and the cellular autophagy system are summarized herein as aspects of the drug resistance mechanism. Simultaneously, effective strategies for addressing drug resistance are elaborated, providing ideas for better clinical treatment of HCC.


Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Humans , Liver Neoplasms/pathology , Carcinoma, Hepatocellular/pathology , Molecular Targeted Therapy , Signal Transduction , Drug Resistance , Drug Resistance, Neoplasm , Cell Line, Tumor , Epithelial-Mesenchymal Transition/physiology
3.
Lett Appl Microbiol ; 69(2): 100-109, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31107978

ABSTRACT

Members of the genus Aeromonas are opportunistic pathogen of a variety of aquatic animals that exhibits multidrug resistance, phenotypes, virulence genes and virulence. The present study described the species distribution and the potential pathogenicity of Aeromonas isolated from healthy Northern snakehead (Channa argus) in China. Molecular identification revealed that A. veronii biovar veronii (69/167; 41·3%) and A. hydrophila (41/167; 24·6%) were the most common species found in Northern snakehead intestine based on sequencing of the 16S rRNA gene and DNA gyrase subunit B protein. The distribution of seven virulence factors including aer (84·4%), act (80·8%), ser (40·1%), Aha (27·5%), lip (23·4%), exu (15·0%) and LuxS (12·6%) were determined exclusively in Aeromonas isolates. All the seven virulence genes were present in 9·6% (16/167), among which 11 strains were identified as A. veronii biovar veronii. For the strains harbouring seven virulence genes, the 50% lethal doses (LD50 ) of isolates were lower compared to the isolates carrying two virulence genes. The challenge tests revealed that isolate W31 had the lowest lethal dose, causing 50% mortality at 4·5 × 103 colony-forming units (CFU) per ml. Furthermore, histopathology of Northern snakehead infected with Aeromonas strains showed necrosis and congestion in liver, spleen and kidney and also damage to the intestine. This study confirms that the Aeromonas strains isolated from healthy Northern snakehead may be a cause of concern for public health. SIGNIFICANCE AND IMPACT OF THE STUDY: Aeromonas species are widely distributed in aquatic environments and have considerable virulence potential. The aim of this study was to identify Aeromonas strains isolated from healthy Northern snakehead, and to investigate if Aeromonas species isolated from healthy fish potential pathogenicity with special reference to virulence and epidemiology studies.


Subject(s)
Aeromonas/pathogenicity , Fish Diseases/microbiology , Gram-Negative Bacterial Infections/veterinary , Virulence Factors/genetics , Aeromonas/genetics , Aeromonas/isolation & purification , Animals , Bacterial Proteins/genetics , China/epidemiology , DNA Gyrase/genetics , Fish Diseases/epidemiology , Fish Diseases/pathology , Fishes , Gram-Negative Bacterial Infections/epidemiology , Gram-Negative Bacterial Infections/microbiology , Gram-Negative Bacterial Infections/pathology , Humans , Public Health , Virulence/genetics
4.
Sleep Breath ; 21(1): 191-195, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28101753

ABSTRACT

PURPOSE: Primary insomnia is a persistent and recurrent disorder as well as a risk factor for depression. The aim of this study was to determine whether the zolpidem combined with paroxetine would be effective in the treatment of patients with primary insomnia. METHODS: Ninety patients meeting DSM-IV criteria for primary insomnia were randomly assigned to 8 weeks of treatment with zolpidem combined with paroxetine (the combined treatment group, n = 45) or zolpidem combined with placebo (the control group, n = 45). Patients were assessed with the Pittsburgh Sleep Quality Index (PSQI), polysomnography (PSG), and the Treatment Emergent Symptom Scale (TESS). RESULTS: Compared with the control group, the combined treatment group was more significantly improved on wake time after sleep onset (WASO), total sleep time (TST), sleep efficiency (SE), and total PSQI scores, but not the sleep onset latency (SOL). CONCLUSIONS: Eight weeks of the zolpidem combined with paroxetine treatment to patients with primary insomnia is more effective than zolpidem treatment only in sleep maintenance and early morning awakenings.


Subject(s)
Paroxetine/adverse effects , Paroxetine/therapeutic use , Pyridines/adverse effects , Pyridines/therapeutic use , Sleep Initiation and Maintenance Disorders/drug therapy , Adult , Drug Therapy, Combination , Female , Humans , Male , Middle Aged , Polysomnography , Treatment Outcome , Wakefulness/drug effects , Zolpidem
6.
Zhonghua Wai Ke Za Zhi ; 28(6): 342-5, 381, 1990 Jun.
Article in Chinese | MEDLINE | ID: mdl-2096058

ABSTRACT

From 1984 to 1986, 56 cases with traumatic paraplegia were treated by transplanting the intact omentum to the injured spinal cord. All patients were followed up 1 to 4 years. In these patients, the sensory level descended variously in 80.0%, muscular power increased in different degrees in 60.9% and sphincter function improved in 76.8%. The indications of this operation are incomplete paraplegia with EMG showing nervous activity. Satisfactory effects can be expected in injuries of the thoracolumbar segments and in mild contusion spinal cord. Fistula with of leak of cerebrospinal fluid, is a severe complication, it may be prevented by suturing the omentum to the dura, complete hemostasis, and tight muscular suturing. The absorb function of the omentum also helps in its prevention.


Subject(s)
Omentum/transplantation , Spinal Cord/surgery , Spinal Injuries/surgery , Adolescent , Adult , Child , Female , Humans , Male , Middle Aged , Paraplegia/surgery , Postoperative Complications/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL